Page last updated: 2024-08-21

methoxyhydroxyphenylglycol and moclobemide

methoxyhydroxyphenylglycol has been researched along with moclobemide in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19903 (23.08)18.7374
1990's10 (76.92)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kallio, A; Karhuvaara, S; Koulu, M; Ojala-Karlsson, P; Scheinin, M1
Berlin, I; Hergueta, T; Payan, C; Puech, AJ; Robin, L; Thiede, HM; Zimmer, R1
Karhuvaara, S; Koulu, M; Scheinin, M; Zimmer, RH1
Alevizos, B; Hatzimanolis, J; Markianos, M; Stefanis, CN2
Kaarttinen, A; Kallio, J; Koulu, M; Pyykkö, K; Scheinin, M; Vuorinen, J; Zimmer, RH1
Böning, J; Fuchs, G; Lensch, K; Milech, U1
Alevizos, B; Hatzimanolis, J; Markianos, M; Stefanis, C1
Dingemanse, J; Kettler, R; Kneer, J; Korn, A; Koulu, M; Wallnöfer, A; Zürcher, G1
Berlin, I; Elatki, S; Ferreri, M; Puech, AJ; Radat, F; Spreux-Varoquaux, O1
Illi, A; Koulu, M; Ojala-Karlsson, P; Scheinin, M1
Amrein, R; Dingemanse, J; Gieschke, R; Guentert, T; Wallnöfer, A1
Birk, KL; Cohen, AF; De Puy, ME; De Smet, M; Fisher, AL; Goldberg, MR; Musson, DG; Sterrett, A; Van Gerven, JM; Van Haarst, AD1

Trials

9 trial(s) available for methoxyhydroxyphenylglycol and moclobemide

ArticleYear
Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers.
    Life sciences, 1991, Volume: 49, Issue:1

    Topics: Adult; Benzamides; Chromatography, High Pressure Liquid; Electrochemistry; Epinephrine; Humans; Imidazoles; Male; Medetomidine; Methoxyhydroxyphenylglycol; Moclobemide; Norepinephrine; Receptors, Adrenergic, alpha; Reference Values

1991
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
    British journal of clinical pharmacology, 1990, Volume: 30, Issue:6

    Topics: Adult; Benzamides; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Psychometrics; Psychophysiology

1990
Evidence that the reversible MAO-A inhibitor moclobemide increases prolactin secretion by a serotonergic mechanism in healthy male volunteers.
    Life sciences, 1990, Volume: 47, Issue:16

    Topics: Adult; Benzamides; Double-Blind Method; Growth Hormone; Humans; Kinetics; Male; Methoxyhydroxyphenylglycol; Methysergide; Moclobemide; Monoamine Oxidase Inhibitors; Prolactin; Random Allocation; Reference Values; Serotonin; Time Factors

1990
Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
    British journal of clinical pharmacology, 1989, Volume: 27, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pituitary Hormones, Anterior; Random Allocation; Selegiline; Vanilmandelic Acid

1989
A clinical study of the selective MAO-A-inhibitor moclobemide (Ro 11-1163): a comparison of 2 different dosages with particular reference to platelet MAO-activity and urinary MHPG-excretion.
    International clinical psychopharmacology, 1987, Volume: 2, Issue:2

    Topics: Adult; Aged; Benzamides; Bipolar Disorder; Blood Platelets; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Moclobemide; Monoamine Oxidase

1987
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
    Clinical neuropharmacology, 1996, Volume: 19, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Double-Blind Method; Drug Interactions; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Selegiline

1996
Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Psychopharmacology, 1996, Volume: 127, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Biomarkers; Depressive Disorder; Double-Blind Method; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors

1996
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome".
    Clinical pharmacology and therapeutics, 1998, Volume: 63, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antidepressive Agents; Benzamides; Blood Platelets; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Reference Values; Selective Serotonin Reuptake Inhibitors; Syndrome

1998
The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers.
    British journal of clinical pharmacology, 1999, Volume: 48, Issue:2

    Topics: Adult; Area Under Curve; Benzamides; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines

1999

Other Studies

4 other study(ies) available for methoxyhydroxyphenylglycol and moclobemide

ArticleYear
Effect of moclobemide on clinical and neurochemical variables in depressed patients (preliminary findings).
    Journal of neural transmission. Supplementum, 1988, Volume: 26

    Topics: Adult; Benzamides; Blood Platelets; Depression; Female; Growth Hormone; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Prolactin; Thyrotropin

1988
Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients.
    Psychiatry research, 1994, Volume: 52, Issue:3

    Topics: Adult; Arousal; Benzamides; Biogenic Amines; Bipolar Disorder; Chromatography, High Pressure Liquid; Depressive Disorder; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Norepinephrine; Personality Inventory; Serotonin

1994
Clinical, endocrine and neurochemical effects of moclobemide in depressed patients.
    Acta psychiatrica Scandinavica, 1993, Volume: 87, Issue:4

    Topics: Adult; Benzamides; Blood Platelets; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Personality Inventory

1993
Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

    Topics: Antiparkinson Agents; Benzamides; Biomarkers; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Norepinephrine; Pentanones; Selegiline

1998